Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1999 3
2000 2
2001 7
2002 5
2003 1
2004 1
2005 3
2006 3
2007 6
2008 6
2009 9
2011 8
2012 3
2013 5
2014 3
2015 9
2016 4
2017 9
2018 4
2019 8
2020 5
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

101 results
Results by year
Filters applied: . Clear all
Page 1
KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors.
Hong DS, Fakih MG, Strickler JH, Desai J, Durm GA, Shapiro GI, Falchook GS, Price TJ, Sacher A, Denlinger CS, Bang YJ, Dy GK, Krauss JC, Kuboki Y, Kuo JC, Coveler AL, Park K, Kim TW, Barlesi F, Munster PN, Ramalingam SS, Burns TF, Meric-Bernstam F, Henary H, Ngang J, Ngarmchamnanrith G, Kim J, Houk BE, Canon J, Lipford JR, Friberg G, Lito P, Govindan R, Li BT. Hong DS, et al. Among authors: munster pn. N Engl J Med. 2020 Sep 24;383(13):1207-1217. doi: 10.1056/NEJMoa1917239. Epub 2020 Sep 20. N Engl J Med. 2020. PMID: 32955176 Free PMC article. Clinical Trial.
Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer.
Terranova-Barberio M, Pawlowska N, Dhawan M, Moasser M, Chien AJ, Melisko ME, Rugo H, Rahimi R, Deal T, Daud A, Rosenblum MD, Thomas S, Munster PN. Terranova-Barberio M, et al. Among authors: munster pn. Nat Commun. 2020 Jul 17;11(1):3584. doi: 10.1038/s41467-020-17414-y. Nat Commun. 2020. PMID: 32681091 Free PMC article. Clinical Trial.
Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma.
Rubenstein JL, Geng H, Fraser EJ, Formaker P, Chen L, Sharma J, Killea P, Choi K, Ventura J, Kurhanewicz J, Lowell C, Hwang J, Treseler P, Sneed PK, Li J, Wang X, Chen N, Gangoiti J, Munster PN, Damato B. Rubenstein JL, et al. Among authors: munster pn. Blood Adv. 2018 Jul 10;2(13):1595-1607. doi: 10.1182/bloodadvances.2017014845. Blood Adv. 2018. PMID: 29986852 Free PMC article. Clinical Trial.
Liver Metastasis and Treatment Outcome with Anti-PD-1 Monoclonal Antibody in Patients with Melanoma and NSCLC.
Tumeh PC, Hellmann MD, Hamid O, Tsai KK, Loo KL, Gubens MA, Rosenblum M, Harview CL, Taube JM, Handley N, Khurana N, Nosrati A, Krummel MF, Tucker A, Sosa EV, Sanchez PJ, Banayan N, Osorio JC, Nguyen-Kim DL, Chang J, Shintaku IP, Boasberg PD, Taylor EJ, Munster PN, Algazi AP, Chmielowski B, Dummer R, Grogan TR, Elashoff D, Hwang J, Goldinger SM, Garon EB, Pierce RH, Daud A. Tumeh PC, et al. Among authors: munster pn. Cancer Immunol Res. 2017 May;5(5):417-424. doi: 10.1158/2326-6066.CIR-16-0325. Epub 2017 Apr 14. Cancer Immunol Res. 2017. PMID: 28411193 Free PMC article. Clinical Trial.
Reply: Strategies to Prevent Cardiotoxicity.
Guglin M, Tamura R, Krischer J, Munster PN. Guglin M, et al. Among authors: munster pn. J Am Coll Cardiol. 2019 Oct 1;74(13):1737-1738. doi: 10.1016/j.jacc.2019.07.047. J Am Coll Cardiol. 2019. PMID: 31558261 Free article. No abstract available.
Maintenance lenalidomide in primary CNS lymphoma.
Rubenstein JL, Geng H, Vu K, Mannis G, Formaker P, Hwang J, Munster PN, Damato B. Rubenstein JL, et al. Among authors: munster pn. Ann Oncol. 2019 Aug 1;30(8):1397-1398. doi: 10.1093/annonc/mdz142. Ann Oncol. 2019. PMID: 31046114 Free article. No abstract available.
Host histone acetylation unlocks HDAC inhibitor potential.
Terranova-Barberio M, Thomas S, Munster PN. Terranova-Barberio M, et al. Among authors: munster pn. Oncotarget. 2017 Nov 13;8(63):106161-106162. doi: 10.18632/oncotarget.22422. eCollection 2017 Dec 5. Oncotarget. 2017. PMID: 29290932 Free PMC article. No abstract available.
101 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page